Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
NY Times, NY
Thu, 11/8/12 - 10:22 pm
Tags:
drug pricing, Sanofi, Sloan Kettering, colon cancer, Zaltrap
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
Tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Sanofi, Novo Nordisk, MannKind
New Drugs for Lipids Set Off Race
NY Times, NY
Tue, 11/6/12 - 12:07 pm
Tags:
PCSK9 inhibitors, Sanofi, Regeneron, Amgen, Pfizer, Roche
Is Big Pharma Dangerously Betting on Huge, Fragile Product Shots?
Forbes
Mon, 11/5/12 - 11:15 am
Tags:
Big Pharma, Sanofi
Regeneron, Sanofi Take Step Forward With Cholesterol Drug
Minyanville
Mon, 11/5/12 - 11:05 am
Tags:
Regeneron, Sanofi, PCSK9, LDL cholesterol, Amgen, AMG145, SAR236553/REGN727
Sanofi draws fire over cost of MS drug Lemtrada
Reuters
Thu, 11/1/12 - 11:51 am
Tags:
MS, multiple sclerosis, Sanofi, Lemtrada
Neuralstem Swinging For The ALS Fences
Seeking Alpha
Mon, 10/29/12 - 11:38 am
Tags:
Neuralstem, ALS, Avanir, Geron, StemCells, NeoStem, Sanofi
New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Tags:
Lpath, Pfizer, iSONEP, Asonept, macular degeneration, multiple sclerosis, MS, Regeneron, Roche, Bayer, Sanofi, Valeant Pharmaceuticals, GSK
Pharma Drug Wars: Two Winners and One Loser
Wall Street Cheat Street
Sat, 10/27/12 - 11:39 am
Tags:
Novartis, AstraZeneca, Sanofi
Sanofi's CEO On The New York Times' Criticism Of Drug Prices And Surviving The Patent Cliff
Forbes
Fri, 10/26/12 - 10:31 am
Tags:
Sanofi, Pharma CEOs, drug pricing, Chris Viehbacher, patents
Sanofi earnings slump in Q3 as competition heats up
Yahoo/AP
Thu, 10/25/12 - 10:53 am
Tags:
earnings, Sanofi
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Tags:
Merck, Sanofi, Eli Lilly, diabetes, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Amylin
4 European Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sun, 10/21/12 - 10:53 am
Tags:
AstraZeneca, GSK, Novartis, Sanofi
This Week in Biotech
Motley Fool
Sun, 10/21/12 - 10:47 am
Tags:
Aegerion, Isis Pharmaceuticals, Sanofi, NPS Pharmaceuticals, Aeterna Zentaris
Isis Pharma/Genzyme FDA Panel Live Blog
TheStreet.com
Thu, 10/18/12 - 11:39 am
Tags:
Genzyme, FDA, Sanofi, Isis Pharmaceuticals, advisory panels, Aegerion, Homozygous Familial Hypercholesterolemia, mipomersen
Pharmas Across The Pond
Motley Fool
Sat, 10/13/12 - 12:30 pm
Tags:
AstraZeneca, GSK, Sanofi
Sanofi Aims to Add Second-Generation Lemtrada to Pipeline
Bloomberg
Fri, 10/12/12 - 12:12 pm
Tags:
Sanofi, Lemtrada, multiple sclerosis, MS, Genzyme
3 Biotechs Facing the Firing Squad Next Week
Motley Fool
Thu, 10/11/12 - 05:42 pm
Tags:
Gattex, NPS Pharmaceuticals, lomitapide, Aegerion, Sanofi, Isis Pharmaceuticals, mipomersen
Bristol Myers' Competition Causes Increased Risk
Seeking Alpha
Thu, 10/11/12 - 11:39 am
Tags:
Bristol-Myers Squibb, Pfizer, Sanofi, Eli Lilly, AstraZeneca
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.